Saturday, 31 October 2026European Markets

NEKKAR Stock Was Up By 22.06% On Wednesday

Loading stream...

(VIANEWS) - The Market ended the session with NEKKAR (NKR.OL) jumping 22.06% to kr7.58 on Wednesday, after two sequential sessions in a row of losses. Oslo Børs Benchmark Index_GI rose 0.39% to kr1,252.12, after three consecutive sessions in a row of gains, on what was a somewhat bullish trend exchanging session today.

NEKKAR's last close was kr6.21, 28.13% under its 52-week high of kr8.64.

About NEKKAR

Nekkar ASA operates in shipyard, aquaculture, renewables, and digital solutions. The company offers shipyard solutions, including Syncrolift shiplift and transfer systems for launching and retrievals of vessels, as well as fast and reliable way of moving vessels around the yard; and FastDocking products for efficient operations during docking and maintenance of vessels. It also offers service and upgrades, shiplift and transfer systems maintenance, spare replacements, and upgrades of small and larger components. In addition, the company offers starfish, an automated and closed cage solution that has double protection against escapes, avoids problems with salmon lice due to water intake from deep waters below the cage, and can collect up to 90 percent of biological waste; and SkyWalker, a wind turbine installation tool. Further, it develops open software platforms for collection, monitoring, and control of data for numerous industries. The company operates in South Asia, North East Asia, Europe, South East Asia, Africa, North America, South America, West Asia, Australia, and internationally. The company was formerly known as TTS Group ASA and changed its name to Nekkar ASA in July 2019. Nekkar ASA founded in 1966 and is headquartered in Kristiansand, Norway.

Earnings Per Share

As for profitability, NEKKAR has a trailing twelve months EPS of kr0.3.

PE Ratio

NEKKAR has a trailing twelve months price to earnings ratio of 25.27. Meaning, the purchaser of the share is investing kr25.27 for every norwegian krone of annual earnings.

Return on Equity

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.79%.

Yearly Top and Bottom Value

NEKKAR's stock is valued at kr7.58 at 22:31 EST, way under its 52-week high of kr8.64 and way higher than its 52-week low of kr5.80.

More news about NEKKAR (NKR.OL).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com